<DOC>
	<DOCNO>NCT01030627</DOCNO>
	<brief_summary>This pilot study document efficacy acceptability administration magnesium sulfate Springfusor pump patient staff two site treatment preeclampsia magnesium sulfate limit available . Currently , sit refer patient tertiary care facility treatment .</brief_summary>
	<brief_title>Treatment Approaches Preeclampsia</brief_title>
	<detailed_description>Women diagnose preeclampsia clinic care team deem would benefit treatment magnesium sulfate give option participate study . Those choose take part study meet study inclusion exclusion criterion receive full information study require give write sign informed consent . Women agree participate study receive load dose maintenance therapy use IV infusion administer Springfusor® pump . Women receive 8 mL load dose contain 4g magnesium sulfate heptahydrate ( MgSO4*7H2O ) 50 % solution , approximately 2 mmoL magnesium/mL . The load dose 8mL 4 g MgSO4 administer use Springfusor® pump . The administration load dose immediately follow maintenance infusion . The maintenance dose 4 g ( 8 cc , 50 % MgSO4 ) administer Springfusor® pump continuously four hour . Clinical monitoring occur every hour treatment period . Clinical monitoring occur throughout treatment , reflex , urine output respiration check least every hour ( , frequent , per standard practice study site ) . The pump check monitoring visit . Prior discharge study , patient ask assess opinion acceptability ease use mode administration . All request inquiry termination treatment record .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Exhibit systolic blood pressure &gt; 140mm Hg OR diastolic pressure &gt; 100 mm Hg Exhibit proteinuria &gt; 1+ Have give birth , 24h less postpartum Exhibit urine output &gt; 100 ml previous 4h great 25 mL/h Agree comply study procedure Be &gt; 18 year age Give inform consent study participation Eclamptic seizing time enrollment Received magnesium sulfate therapy 24h prior study enrollment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Eclampsia</keyword>
	<keyword>Preeclampsia</keyword>
	<keyword>Magnesium sulfate</keyword>
</DOC>